clarithromycin has been researched along with Pneumonia, Pneumococcal in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasahara, K; Kita, E; Mikasa, K; Mizuno, F; Nishi, K; Yasuda, Y | 1 |
| Asakura, T; Asami, T; Atarashi, K; Betsuyaku, T; Fujii, H; Hasegawa, N; Hegab, AE; Honda, K; Ishii, M; Iwata, S; Kamata, H; Kanai, T; Koyasu, S; Nakamoto, N; Namkoong, H; Suzuki, S; Tasaka, S; Yagi, K | 1 |
| Arnold, C; Bassetti, S; Piso, RJ | 1 |
| Aolie, J; El-Khatib, WF; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
| Barman, TK; Bhadauria, T; Bhateja, P; Bhatnagar, PK; Chakrabarti, A; Das, B; Katoch, R; Kumar, GR; Malhotra, S; Mathur, T; Pandya, M; Rao, M; Rathy, S; Upadhyay, D; Venkataraman, R | 1 |
| Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
| Carbonnelle, S; De Bel, A; Dediste, A; Glupczynski, Y; Huang, TD; Jacobs, F; Jordens, P; Lismond, A; Schatt, P; Tulkens, PM; Van Bambeke, F; Verhaegen, J; Verschuren, F | 1 |
| Guchev, IA; Klochkov, OI; Ul'ianov, VA | 1 |
| Banevicius, MA; Capitano, B; Maglio, D; Nicolau, DP; Nightingale, CH; Tessier, PR | 1 |
| Guchev, IA; Klochkov, OI; Kozlov, RS; Sinopalnikov, A; Stratchounski, LS; Yu, VL | 1 |
| Banevicius, MA; Du, X; Lee, SY; Maglio, D; Nicolau, DP; Sun, HK | 1 |
| Lee, WK; Young, BW | 1 |
| Pocidalo, JJ; Veber, B | 1 |
| Amougou, M; Fossion, M; Mengeot, PM; Vandeven, J; Verbiest, N; Verbist, L; Verhaegen, J | 1 |
| Bharani, A; Kumar, H | 1 |
| Kim, MK; Li, C; Nicolau, DP; Nightingale, CH; Tessier, PR; Xuan, D; Ye, M; Zhou, W | 1 |
| Azoulay-Dupuis, E; Bédos, JP; Pocidalo, JJ; Vallée, E; Veber, B | 1 |
2 trial(s) available for clarithromycin and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
[Evaluation of clarithromycin efficacy in the treatment of community-acquired pneumonia on the basis of the Binax NOW test results (a prospective open trial)].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antigens, Bacterial; Chromatography; Clarithromycin; Community-Acquired Infections; Gastrointestinal Diseases; Humans; Immunologic Techniques; Male; Military Personnel; Pneumonia, Pneumococcal; Prospective Studies; Reagent Kits, Diagnostic; Sputum; Streptococcus pneumoniae; Urticaria | 2002 |
Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Clarithromycin; Humans; Male; Military Personnel; Pneumonia, Pneumococcal; Prospective Studies | 2005 |
15 other study(ies) available for clarithromycin and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Disease Models, Animal; Drug Resistance, Bacterial; Lung; Macrolides; Male; Matrix Metalloproteinase 7; Mice; Mice, Inbred CBA; Pneumonia, Pneumococcal; Roxithromycin; Streptolysins | 2007 |
Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia.
Topics: Animals; Anti-Bacterial Agents; CD11b Antigen; Cell Differentiation; Cell Proliferation; Clarithromycin; Gastrointestinal Hormones; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myeloid Cells; Neuropeptides; Orthomyxoviridae; Orthomyxoviridae Infections; Phagocytosis; Pneumonia, Pneumococcal; Shock, Septic; STAT3 Transcription Factor; Streptococcus pneumoniae | 2018 |
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index | 2013 |
Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Ketolides; Microbial Sensitivity Tests; Monte Carlo Method; Pneumonia, Pneumococcal; Probability; Streptococcus pneumoniae | 2009 |
Activity of a novel series of acylides active against community-acquired respiratory pathogens.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Evaluation, Preclinical; Haemophilus influenzae; Humans; Mice; Microbial Sensitivity Tests; Moraxella catarrhalis; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Time Factors | 2010 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; beta-Lactams; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Comorbidity; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Vaccination; Young Adult | 2012 |
Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistance.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Immunocompromised Host; Lung; Membrane Proteins; Methyltransferases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2004 |
Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model.
Topics: Administration, Oral; Amoxicillin; Animals; Bacterial Proteins; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Membrane Proteins; Methyltransferases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Pulse Therapy, Drug; Streptococcus pneumoniae | 2005 |
Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Community-Acquired Infections; Drug Prescriptions; Erythromycin; Hong Kong; Humans; Infant; Penicillin Resistance; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Prevalence; Streptococcus pneumoniae | 2005 |
[The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Injections, Subcutaneous; Mice; Pneumonia, Pneumococcal; Roxithromycin; Spiramycin | 1995 |
Impredictable susceptibility for cephalosporins in penicillin resistant Streptococcus pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Clarithromycin; Drug Therapy, Combination; Female; Humans; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1997 |
Drug points: Diabetes inspidus induced by ofloxacin.
Topics: Adult; Anti-Infective Agents, Urinary; Clarithromycin; Diabetes Insipidus; Drug Therapy, Combination; Gentamicins; Humans; Male; Metronidazole; Ofloxacin; Penicillin G; Pneumonia, Pneumococcal | 2001 |
Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Lung; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2002 |
Individual efficacy of clarithromycin (A-56268) and its major human metabolite 14-hydroxy clarithromycin (A-62671) in experimental pneumococcal pneumonia in the mouse.
Topics: Animals; Clarithromycin; Erythromycin; Female; Lung; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1992 |